CALLAN JMB INC. financials

CJMB CIK 0002032545

Source: EDGAR filings · Built 2026-06-19T02:09:06Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -5.16M 494.19K 6.51M
EBITDA -6.88M -2.13M 2.30M
Working Capital 1.65M 2.04M 7.68M
Net Debt -143.59K -1.19M -4.76M
Gross Margin 36.77% 39.05% 42.79%
Operating Margin -122.91% -34.66% 16.68%
Net Margin -139.19% -34.95% 16.52%
Return on Equity (ROE) -342.19% -72.28% 24.80%
Return on Assets (ROA) -137.93% -45.13% 22.47%
Current Ratio 2.16× 2.60× 10.98×
Debt-to-Equity 0.85× 0.29× 0.05×
Effective Tax Rate 0.04% -1.12% 1.04%
Cash Conversion Ratio 0.57× -0.24× 3.21×
Accruals Ratio -0.59× -0.56× -0.50×
SBC % of Revenue 27.25%
CapEx Coverage -7.37× 11.70× 14.28×
Free Cash Flow Per Share $-1.18 $0.19

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 5.72M 6.56M 13.20M
Revenues 5.72M 6.56M 13.20M
Cost of Revenue 3.62M 4.00M 7.55M
Gross Profit 2.10M 2.56M 5.65M
Selling, General and Administrative Expense 8.60M 4.84M 3.45M
Operating Income (Loss) -7.03M -2.27M 2.20M
Income Tax Expense (Benefit) -2.96K 25.37K 23.00K
Net Income (Loss) Attributable to Parent -7.97M -2.29M 2.18M
Earnings Per Share, Basic $-1.82 $-0.87
Weighted Average Number of Shares Outstanding, Basic 4.38M 2.63M
Earnings Per Share, Diluted $-1.82 $-0.87
Weighted Average Number of Shares Outstanding, Diluted 4.38M 2.63M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 2.13M 2.10M 5.16M
Assets, Current 3.06M 3.32M 8.45M
Assets 5.78M 5.08M 9.71M
Liabilities, Current 1.41M 1.27M 769.71K
Liabilities 3.45M 1.91M 910.27K
Stockholders' Equity Attributable to Parent 2.33M 3.17M 8.80M
Common Stock, Shares, Outstanding 4.86M 3.00M 0

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CJMB CIK 0002032545), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CGTX

Cognition Therapeutics, Inc.

LFST

LifeStance Health Group, Inc.

SVBL

SILVER BULL RESOURCES, INC.